Inhalation therapy in cystic fibrosis

Inhalation therapy in cystic fibrosis

Authors

  • Vincenzo Carnovale Cystic Fibrosis Adult Unit - Department of Traslational Science - University of Naples “Federico II”
  • P. Iacotucci Cystic Fibrosis Adult Unit - Department of Traslational Science - University of Naples “Federico II”
  • M. Cellurale Cystic Fibrosis Adult Unit - Department of Traslational Science - University of Naples “Federico II”
  • M. D'Ippolito Cystic Fibrosis Adult Unit - Department of Traslational Science - University of Naples “Federico II”
  • S. Buonaurio Cystic Fibrosis Adult Unit - Department of Traslational Science - University of Naples “Federico II”
  • A. Celardo Cystic Fibrosis Adult Unit - Department of Traslational Science - University of Naples “Federico II”
  • N. Ferrara Cystic Fibrosis Adult Unit - Department of Traslational Science - University of Naples “Federico II”

Keywords:

cystic fibrosis, inhaled medication, inhalation devices

Abstract

In Cystic Fibrosis (CF) inhalation of drugs to treat lung disease has been proven to be highly effective. An increasing number of drugs and devices have been developed for CF lung disease. In this article we will review the current status of inhaled medication in CF, including the various drugs, their modes of administration and indications, and their effects. We will address antibiotics, mucolytics/mucous mobilizers, antiinflammatory drugs, bronchodilators and combinations of solutions. We will review the current knowledge on devices for inhalation therapy with regard to optimal particle sizes and characteristics of wet nebulisers, dry powder and metered dose inhalers.

Downloads

How to Cite

1.
Carnovale V, Iacotucci P, Cellurale M, D'Ippolito M, Buonaurio S, Celardo A, et al. Inhalation therapy in cystic fibrosis. Acta Biomed [Internet]. 2014 Dec. 9 [cited 2024 Jul. 24];85(4):7-9. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/4081